(Q37461977)

20 August 2017

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older (English)

1 reference

20 August 2017

cervix uterine cancer

1 reference

Eduardo L Franco

5

0 references

Joakim Dillner

10

object named as

Joakim Dillner

1 reference

20 August 2017

Daniëlle A M Heideman

11

object named as

Daniëlle A M Heideman

1 reference

20 August 2017

3

Philip E Castle

1 reference

20 August 2017

9

Jack Cuzick

1 reference

20 August 2017

1

Chris J L M Meijer

1 reference

Francesc Xavier Bosch José

20 August 2017

8

object named as

F Xavier Bosch

1 reference

20 August 2017

12

Peter J F Snijders

1 reference

20 August 2017

Johannes Berkhof

2

1 reference

20 August 2017

Albertus T Hesselink

4

1 reference

20 August 2017

Guglielmo Ronco

6

1 reference

20 August 2017

Marc Arbyn

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

International Journal of Cancer

20 August 2017

1 reference

20 August 2017

124

1 reference

20 August 2017

516-520

1 reference

20 August 2017

3

1 reference

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

HPV-mediated cervical carcinogenesis: concepts and clinical implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Management of women who test positive for high-risk types of human papillomavirus: the HART study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Epidemiologic classification of human papillomavirus types associated with cervical cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Interlaboratory reliability of Hybrid Capture 2.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

On tests of equivalence via non-unity relative risk for matched-pair design

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789446

Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months

3 December 2018

1 reference

12 December 2020

Human papillomavirus and cervical cancer

1 reference

12 December 2020

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

12 December 2020

Why CIN3 and CIN2 should be distinguished on histological reports

1 reference

12 December 2020

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types

1 reference

12 December 2020

A study of the impact of adding HPV types to cervical cancer screening and triage tests

1 reference

12 December 2020

Carcinogenicity of human papillomaviruses

1 reference

12 December 2020

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

12 December 2020

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.24010

1 reference

20 August 2017

1 reference

20 August 2017

1 reference